Mikael Jondal
#125,592
Most Influential Person Now
Mikael Jondal's AcademicInfluence.com Rankings
Mikael Jondalbiology Degrees
Biology
#7919
World Rank
#10914
Historical Rank
Immunology
#433
World Rank
#450
Historical Rank
Download Badge
Biology
Why Is Mikael Jondal Influential?
(Suggest an Edit or Addition)Mikael Jondal's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES (1972) (2224)
- SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES (1973) (481)
- Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. (1972) (432)
- Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro (1977) (356)
- Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. (1975) (334)
- Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. (1989) (314)
- Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations (1975) (302)
- MHC class I-restricted CTL responses to exogenous antigens. (1996) (294)
- Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. (1974) (293)
- Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. (1989) (288)
- Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. (1990) (261)
- Cellular signalling in programmed cell death (apoptosis). (1990) (261)
- Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. (1991) (204)
- Recycling and target binding capacity of human natural killer cells (1981) (189)
- Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. (1975) (186)
- Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies (1982) (184)
- EBV‐determined nuclear antigen (EBNA)‐positive cells in the peripheral blood of infectious mononucleosis patients (1976) (183)
- Self-replicating Semliki Forest virus RNA as recombinant vaccine. (1994) (173)
- Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems (1976) (167)
- Surface Markers on Human B and T Lymphocytes (1976) (166)
- Bcl‐2, Bax and p53 expression in B‐CLL in relation to in vitro survival and clinical progression (1996) (157)
- Surface Markers on Human B and T Lymphocytes (1974) (147)
- Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. (1995) (126)
- Paracrine glucocorticoid activity produced by mouse thymic epithelial cells (1999) (126)
- Surface markers on human B‐ and T‐lymphocytes. IX. Two‐color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines (1976) (126)
- Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL. (1999) (125)
- Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. (1990) (124)
- Interleukin 1 inhibits T cell receptor-mediated apoptosis in immature thymocytes. (1990) (123)
- TUMOR INFILTRATING LYMPHOCYTES * (1976) (123)
- Polyunsaturated free fatty acids stimulate an increase in cytosolic Ca2+ by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in T cells through a mechanism independent of phosphoinositide turnover. (1990) (123)
- Human Lymphocyte Subpopulations: Classification According to Surface Markers and/or Functional Characteristics (1973) (111)
- Effects of altered glucocorticoid sensitivity in the T‐cell lineage on thymocyte and T‐cell homeostasis (2002) (106)
- Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. (1987) (105)
- Human spontaneous killer cells selective for tumour-derived target cells (1978) (100)
- CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. (1997) (99)
- IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. (1988) (91)
- Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma (1990) (91)
- Immunization with glycosylated Kb‐binding peptides generates carbohydrate‐specific, unrestricted cytotoxic T cells (1996) (90)
- Different roles for glucocorticoids in thymocyte homeostasis? (2004) (87)
- High expression of Bfl‐1 contributes to the apoptosis resistant phenotype in B‐cell chronic lymphocytic leukemia (2005) (84)
- Cellular signaling in thymocyte apoptosis. (1992) (84)
- Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation (1976) (83)
- Inducibility of the Epstein‐Barr virus (EBV) cycle and surface marker properties of ebv‐negative lymphoma lines and their in vitro EBV‐converted sublines (1976) (82)
- Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease. (1982) (82)
- Killer T cells in a Burkitt's lymphoma biopsy (1975) (81)
- NK cell‐induced cytotoxicity is dependent on a Ca2+ increase in the target (1990) (81)
- Estrogen receptor α and β in the normal immune system and in lymphoid malignancies (2013) (76)
- Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D (2001) (76)
- In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity (1978) (76)
- Target-effector interaction in the human and murine natural killer system: specificity and xenogeneic reactivity of the solubilized natural killer-target structure complex and its loss in a somatic cell hybrid (1979) (75)
- SRBC Rosette Formation as a Human T Lymphocyte Marker (1976) (75)
- Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis. (1978) (74)
- Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor1 (2007) (71)
- Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene (1999) (69)
- Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo (2011) (68)
- Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. (1995) (67)
- Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia (2007) (61)
- The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation. (1994) (61)
- Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes. (1995) (61)
- Extra-adrenal glucocorticoid synthesis: Immune regulation and aspects on local organ homeostasis (2013) (58)
- Cyclic AMP potentiates glucocorticoid‐induced endogenous endonuclease activation in thymocytes 1 (1993) (58)
- Somatic cell hybrids between human lymphoma lines. III. Surface markers (1977) (58)
- In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. (1992) (54)
- Major histocompatibility complex class I‐binding peptides are recycled to the cell surface after internalization (1993) (54)
- Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis. (1976) (53)
- Age-related synthesis of glucocorticoids in thymocytes. (2008) (53)
- Inhibition of receptor-mediated calcium influx in T cells by unsaturated non-esterified fatty acids. (1990) (50)
- Inhibition of Human NK Cell Cytotoxicity by Induction of Cyclic AMP Depends on Impaired Target Cell Recognition (1983) (48)
- Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection. (1989) (48)
- Immunotherapy with recombinant SFV‐replicons expressing the P815A tumor antigen or IL‐12 induces tumor regression (2002) (47)
- TAP2‐defective RMA‐S cells present Sendai virus antigen to cytotoxic T lymphocytes (1993) (47)
- Sensitization of Human Lymphocytes Against Autologous or Allogeneic Lymphoblastoid Cell Lines: Characteristics of the Reactive Cells (1974) (46)
- Interferon‐Induced NK Augmentation in Humans (1981) (46)
- Conditional expression of a glucocorticoid receptor transgene in thymocytes reveals a role for thymic-derived glucocorticoids in thymopoiesis in vivo. (2005) (46)
- TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. (1997) (45)
- Phosphoinositide breakdown and evidence for protein kinase C involvement during human NK killing. (1988) (44)
- Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients. (1989) (43)
- Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression. (1991) (43)
- Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells (2004) (43)
- Thymus-derived glucocorticoids mediate androgen effects on thymocyte homeostasis. (2010) (42)
- Interleukin‐10 mRNA expression in B‐cell chronic lymphocytic leukaemia inversely correlates with progression of disease (1996) (42)
- Spontaneous production of interleukin 1 activity by chronic lymphocytic leukemic cells. (1987) (42)
- Thymocyte-synthesized glucocorticoids play a role in thymocyte homeostasis and are down-regulated by adrenocorticotropic hormone. (2009) (41)
- The regulation of apoptosis in thymocytes. (1994) (41)
- Surface Markers on Human B and T Lymphocytes (1974) (41)
- Spontaneous human lymphocyte‐mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells? (1977) (41)
- Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity. (2010) (39)
- Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies. (1975) (39)
- Diagnostic implication of specific immunoglobulin G patterns of children born to HIV‐infected mothers (1989) (38)
- Characterization of the phorbol 12,13-dibutyrate (P(Bu)2) induced binding between human lymphocytes. (1983) (37)
- Influence of IgG and IgM receptor triggering on human natural killer cell cytotoxicity measured on the level of the single effector cell (1981) (37)
- Serum levels of helper factors (IL-1α, IL-1β and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and β2-microglobulin in patients with B-CLL and benign B lymphocytosis (1992) (34)
- In vitro studies of lymphocytes from patients with plasma cell myeloma. II. Characterization by cell surface markers. (1973) (33)
- Stimulation of T-cells with OKT3 antibodies increases forskolin binding and cyclic AMP accumulation. (1990) (33)
- Functional glucocorticoid receptor expression is required for cAMP-mediated apoptosis in a human leukemic T cell line. (1995) (33)
- Mitogen stimulation of T-cells increases c-Fos and c-Jun protein levels, AP-1 binding and AP-1 transcriptional activity. (1992) (32)
- Alternative processing for MHC class I presentation by immature and CpG‐activated dendritic cells (2004) (32)
- Increased serum levels of soluble Fas in progressive B‐CLL (2001) (31)
- Induction of cytotoxic T‐cell response by optimal‐length peptides does not require CD4+ T‐cell help (1996) (31)
- Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro. (1987) (31)
- Glucocorticoids delay age-associated thymic involution through directly affecting the thymocytes. (2004) (30)
- Characterization of TAP‐Independent and Brefeldin A‐Resistant Presentation of Sendai Virus Antigen to CD8+ Cytotoxic T Lymphocytes (1995) (30)
- Regulatory effects of dexamethasone on NK and T cell immunity (2017) (30)
- Stimulation of Normal Lymphocytes with Autologous Lymphoid Cell Lines: Properties of Derived Killer Cells (1975) (30)
- Suppression of growth in a leukemic T cell line by n−3 and n−6 polyunsaturated fatty acids (1989) (29)
- Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response (2001) (29)
- In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up‐regulation of major histocompatibility complex class I molecules by short synthetic peptides (1992) (29)
- Evidence for protein tyrosine kinase involvement in CD6-induced T cell proliferation. (1995) (27)
- A role for glucocorticoids in the thymus? (2001) (27)
- The human NK cell--a short over-view and an hypothesis on NK recognition. (1987) (27)
- Ca2+ entry in T cells is activated by emptying the inositol 1,4,5-triphosphate sensitive Ca2+ pool. (1990) (26)
- Herpesvirus-transformed cytotoxic T-cell lines (1981) (26)
- Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization. Characterization and epitope mapping. (1989) (26)
- Regulation of calcium influx across the plasma membrane of the human T-leukemic cell line, JURKAT: dependence on a rise in cytosolic free calcium can be dissociated from formation of inositol phosphates. (1990) (25)
- Thymocyte apoptosis by glucocorticoids and cAMP. (1995) (25)
- Glycosylphosphatidylinositol‐linked Db does not induce an influenza‐specific cytotoxic T lymphocyte response or recycle membrane‐bound peptides (1995) (25)
- 7alpha-Hydroxylation and 3-dehydrogenation abolish the ability of 25-hydroxycholesterol and 27-hydroxycholesterol to induce apoptosis in thymocytes. (1997) (25)
- Monocyte-induced human natural killer cell suppression followed by increased cytotoxic activity during short-term in vitro culture in autologous serum. (1981) (24)
- Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains. (1988) (24)
- Products of the lipoxygenase pathway in human natural killer cell cytotoxicity. (1985) (23)
- Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I. (1988) (23)
- Positive and negative thymic selection in T cell receptor‐transgenic mice correlate with Nur77 mRNA expression (1997) (23)
- Regulation of B-CLL apoptosis through membrane receptors and Bcl-2 family proteins. (1998) (23)
- Modification of membrane phospholipid fatty acyl composition in a leukemic T cell line: effects on receptor mediated intracellular Ca2+ increase. (1991) (23)
- Monolayer immune complex (MIC) fractionation of Fc receptor bearing human spontaneous killer cells. (1978) (23)
- Translocation of the α‐ and β‐isoforms of protein kinase C following activation of human T‐lymphocytes (1991) (23)
- Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC. (2008) (21)
- Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS). (1989) (21)
- Regulation of receptor-mediated calcium influx across the plasma membrane in a human leukemic T-cell line: evidence of its dependence on an initial calcium mobilization from intracellular stores. (1988) (21)
- Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro. (1994) (21)
- Surface Markers on Human B and T Lymphocytes (1975) (21)
- Co-receptor (CD4/CD8) engagement enhances CD3-induced apoptosis in thymocytes. Implications for negative selection. (1994) (21)
- Phorbol ester-induced adhesion (binding) among human mononuclear leukocytes requires extracellular Mg++ and is sensitive to protein kinase C, lipoxygenase, and ATPase inhibitors. (1985) (20)
- Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies. (1991) (20)
- SPONTANEOUS CYTOTOXIC ACTIVITY AS A TEST OF HUMAN LYMPHOCYTE FUNCTION (1975) (19)
- Characterization of PHA and anti-T3 induced transduction mechanisms in a human T-cell leukaemia line. (1987) (19)
- Monoclonal antibodies to p24-core protein of HIV-1 mediate ADCC and inhibit virus spread in vitro. (1995) (19)
- Studies on the calcium dependence of human NK cell killing. (1987) (19)
- Cytokine expression in B-CLL in relation to disease progression andin vitro activation (1999) (18)
- The adenosine receptor mediated accumulation of cyclic AMP in Jurkat cells is enhanced by a lectin and by phorbol esters. (1987) (18)
- Distribution of IgG and IgM receptors on human peripheral natural killer cells measured on the level of the single effector cell (1981) (17)
- Herpesvirus ateles and herpesvirus saimiri transform marmoset T cells into continuously proliferating cell lines that can mediate natural killer cell-like cytotoxicity. (1981) (17)
- Phorbol ester regulation of Ca2+ flux during natural, lectin and antibody-dependent killing. (1986) (16)
- Local glucocorticoid production in the thymus (2015) (16)
- 1,25-Dihydroxyvitamin D3 and phorbol esters (TPA) may induce select in vitro differentiation pathways in the HL60 promyelocytic cell line. (1987) (16)
- Modification of anti-tumor immunity by tolerogenic dendritic cells (2017) (16)
- Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein GP120 epitopes correlates with the uninfected status of children born to seropositive mothers. (1990) (16)
- PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP. (1983) (15)
- EBV specific killer T cells and serologic responses after onset of infectious mononucleosis. (1978) (15)
- Quantitation of DNA fragmentation using fiberglass filters. (1989) (15)
- Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis. (1992) (15)
- Glucocorticoid resistance in thymocytes from mice expressing a T cell receptor transgene. (2000) (15)
- Antibody-dependent cellular cytotoxicity detects type- and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates (1989) (15)
- Characterization of insulin binding to the erythroleukemia cell line K 562. (1983) (14)
- MHC Class I Presentation of Live and Heat‐Inactivated Sendai Virus Antigen in T2Kb Cells Depends on an Intracellular Compartment with Endosomal Characteristics (1997) (14)
- CD3-dependent increase in cyclic AMP in human T-cells following stimulation of the CD2 receptor. (1991) (13)
- Endolysosomal Processing of Exogenous Antigen into Major Histocompatibility Complex Class I‐Binding Peptides (2004) (13)
- CD3/T‐cell receptor coupling to a pertussis and cholera toxin‐insensitive G‐protein (1989) (13)
- Low IL-1 beta production in leukemic cells from progressive B cell chronic leukemia (B-CLL). (1989) (13)
- Functional studies on tumor-infiltrating lymphocytes in man. (1977) (12)
- Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development. (1977) (12)
- Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2. (1991) (12)
- Free Oxygen Radicals Are Not Detectable by Chemiluminescence during Human Natural Killer Cell Cytotoxicity (1984) (11)
- Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC. (2008) (11)
- Toxic effects of interleukin-2-activated lymphocytes on vascular endothelial cells. (1991) (11)
- Spontaneous and lectin-dependent cellular cytotoxicity by lymphocyte subpopulations against cell lines susceptible or resistant to spontaneous cytotoxicity. (1978) (10)
- Effect of 5′‐Methylthioadenosine, 3‐Deazaadenosine, and Related Compounds on Human Natural Killer Cell Activity (1984) (10)
- CD6 ligation modulates BCL-2/BAX ratio and protects B-CLL cells from apoptosis induced by ANTI-IgM (1996) (10)
- Antibody‐dependent cell‐mediated cytotoxic activity in syngeneic mouse ascites tumors (1975) (9)
- Monoclonal antibodies against the NK cell-FcR and the T3-complex potentiate normal lymphocyte killing. (1986) (9)
- Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging. (1977) (9)
- TLR9 Activation Increases TAP‐Independent Vesicular MHC Class I Processing In vivo (2009) (8)
- HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization. (1989) (8)
- Evidence that Protein Kinase C Activation is Essential for Killing by IL‐2‐Activated Lymphocytes (1990) (8)
- A central role for phosphoinositide hydrolysis in activating the lytic mechanism of human natural killer cells. (1990) (7)
- Major histocompatibility complex class I binding glycopeptides for the estimation of 'empty' class I molecules. (1995) (7)
- Second Messenger Function of Arachidonic Acid Lipoxygenation Products in Human Natural Killer Cell Lysis? (1985) (7)
- Natural Killer and T‐Cell Potentiation by Monoclonal IgG against Natural Killer Cell FcR(IgG) or the T3 Complex (1986) (7)
- Loading of the Antigen‐Presenting Protein CD1d with Synthetic Glycolipids (2004) (7)
- IGHV3‐21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia (2010) (7)
- Phospholipase C treatment of certain human target cells reduces their susceptibility to NK lysis without affecting binding or sensitivity to lytic granules. (1991) (6)
- Agonistic Effects of Anti‐CD2 and Anti‐CD16 Antibodies on Human Natural Killer Killing (1989) (6)
- Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with Staphylococcus aureus and anti-CD40 monoclonal antibodies. (1993) (6)
- Gal alpha 4Gal-binding antibodies: specificity and use for the mapping of glycolipids of Burkitt lymphoma and other human tumors. (1996) (6)
- Decreased Natural Killer (NK) Susceptibility of Human NK Target Cells after Phosphatidylinositol‐Specific Phospholipase C Treatment (1989) (6)
- Interference with O‐glycosylation in RMA lymphoma cells leads to a reduced in vivo growth of the tumor (2006) (6)
- The selective impact of transgenically expressed glucocorticoid receptor on T cells (2015) (5)
- Regulation of MHC Class I Membrane Expression by β2‐Microglobulin (1993) (5)
- SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus. (1991) (5)
- Bone marrow modulaton of spontaneous killer cellular cytotoxicity (SKCC) induction. (1980) (5)
- External glycopeptide binding to MHC class-I in relation to expression of TAP transporters, beta 2-microglobulin and to pH. (1996) (5)
- PRESENCE OF FcR FOR IgG AND IgM ON HUMAN NK CELLS: THE ROLE OF IMMUNE COMPLEXES IN THE REGULATION OF NK CELL CYTOTOXICITY (1982) (5)
- Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells. (1983) (4)
- Membrane expression of IL-1 alpha in chronic B lymphocytic leukemia. (1993) (4)
- A method for analysis of cellular K-transport mechanisms through thallium (201Tl) uptake in human lymphocytes. (1994) (4)
- In vivo and in vitro selection of mitogen responsive lymphocytes in patients with chronic lymphocytic leukemia. (1976) (3)
- Epstein-Barr Virus (EBV) Specific T and K Cell Cytotoxicity in vitro1 (1976) (3)
- HUMAN NK CELL ACTIVATION WITH INTERFERON AND WITH TARGET CELL-SPECIFIC IgG (1982) (3)
- Potentiation of transmembrane signaling by cross-linking of antibodies against the beta chain of the T cell antigen receptor of JURKAT T cells. (1992) (3)
- Activation of protein kinase C via the T-cell receptor complex potentiates cyclic AMP responses in T-cells (1989) (3)
- Classification of lymphocytes in naso pharyngeal carcinoma biopsies (1975) (2)
- Stimulation of the T-cell receptors CD3 and CD2 with OKT3 and OKT11 antibodies activates a common pertussis toxin-insensitive G-protein. (1990) (2)
- Thymus‐derived glucocorticoids mediate androgen effects on thymocyte homeostasis (2010) (2)
- Regulation of MHC class I membrane expression by beta 2-microglobulin. (1993) (2)
- Keratinocyte growth factor (KGF) delays the onset of collagen-induced arthritis (2012) (2)
- The lipoxygenase pathway in the human NK cell system. (1985) (2)
- Induction of K562 lysis in autologous LGL and dense T cell cocultures. (1985) (1)
- Lack of Fc receptor expression on cytotoxic effector cells with spontaneous killer (SK) cell specificity induced by stimulation with B cell lines. (1979) (1)
- NATURAL KILLER CELL-LIKE CYTOTOXICITY MEDIATED BY HERPESVIRUS TRANSFORMED MARMOSET T CELL LINES (1982) (1)
- Epstein-Barr virus (EBV) specific T and K cell cytotoxicity in vitro. (1975) (1)
- INCREASE IN INTRA-CELLULAR LEVELS OF CYCLIC AMP INHIBITS TARGET CELL RECOGNITION BY HUMAN NK CELLS (1982) (1)
- TumorCTL Response against the P815 the Generation of a Protective Central ALVAC Vectors Demonstrate Differences in Semliki Forest Virus, Adenovirus, and Comparative Prime-Boost Vaccinations Using (2013) (1)
- Regulatory effects of dexamethasone on NK and T cell immunity (2017) (1)
- Different human hematopoetic cell lines, susceptible or resistant to NK lysis, conjugate identically to non-adherent peripheral blood lymphocytes. (1982) (1)
- Antibody-dependent cell-mediated cytotoxic activity in syngeneic moouse ascites tumors. (1975) (0)
- Virus induced immunoprophylaxis to a gross murine leukemia virus (gmulv) induced syngeneic lymphoma. Abstr. (1978) (0)
- Conjugated peptide-carbohydrate that generate T cell immunity (1993) (0)
- LOADING OF ANTIGEN PRESENTING MOLECULES: CD1-BINDING LIPIDS CARRYING THE TUMOR ANTIGEN ALPHA-N-ACETYL-GALACTOSAMINE (2002) (0)
- Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37]. (2017) (0)
- AGONIST FUNCTION OF ANTI-CD2 AND ANTI-CD16 MONOCLONAL ANTIBODIES ON HUMAN NK KILLING (1987) (0)
- Translocation of the alpha- and beta-isoforms of protein kinase C following activation of human T-lymphocytes. (1991) (0)
- 1,25(0H)2D3 and TPA may induce select differentiation pathways in theHL60 promyelocytic cell line. (1987) (0)
- Interactions between the Modulator Adenosine and Classical Transmitters (1987) (0)
- leukemic cells Spontaneous production of interleukin 1 activity by chronic lymphocytic (2011) (0)
- Tumor Memory CTL Response against the P 815 the Generation of a Protective Central ALVAC Vectors Demonstrate Differences in Semliki Forest Virus , Adenovirus , and Comparative Prime-Boost Vaccinations Using Benoi ? (2007) (0)
- HUMAN NATURAL KILLER CELLS : RECYCLING AND TARGET (2003) (0)
- Brief DeNnltive Report (1982) (0)
- [Cellular immunity in HIV infection]. (1987) (0)
- Cellular Cytotoxicity Detects Type-andStrain- Specific Antigens amongHumanImmunodeficiency Virus Types1 and2andSimian Immunodeficiency VirusSlVmac Isolates (1989) (0)
- CYTOKINE EXPRESSION IN PROGRESSIVE AND NON-PROGRESSIVE B-CLL (1996) (0)
- The Role of Calcium in Lymphocyte Regulation (1993) (0)
- [Cancer therapy with interleukin 2 and activated killer cell--a review]. (1987) (0)
- MHC Class I H-2KB Presented Glycopeptide RGY8-6H-GAL2 (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mikael Jondal?
Mikael Jondal is affiliated with the following schools:
